RHI
40
-3
MMM
28
-5
NFLX
61
2
AME
60
-3
EXR
53
-2
EXC
47
-4
FLR
43
3
GRMN
59
-3
VRSN
53
-2
DE
25
-4
COST
69
2
BEN
49
-3
NUE
34
-5
ADSK
72
2
VTR
55
-6
MAT
39
-4
PX
59
-3
DOW
52
-2
O
37
-5
BAC
45
-5
RHI
40
-3
MMM
28
-5
NFLX
61
2
AME
60
-3
EXR
53
-2
EXC
47
-4
FLR
43
3
GRMN
59
-3
VRSN
53
-2
DE
25
-4
COST
69
2
BEN
49
-3
NUE
34
-5
ADSK
72
2
VTR
55
-6
MAT
39
-4
PX
59
-3
DOW
52
-2
O
37
-5
BAC
45
-5
Financhill
Back

Entero Therapeutics 10K Form

Sell
4

ENTO
Entero Therapeutics

Last Price:
1.76
Seasonality Move:
-38.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENTO News And Ratings

See the #1 stock for the next 7 days that we like better than ENTO

ENTO Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-3.75M
Price / Cash Flow: 0
Annual Sales: $7.99
Price / Book: 0.32

Profitability

EPS (TTM): -49.29650
Net Income (TTM): $-6.16M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Entero Therapeutics Earnings Forecast

Key Entero Therapeutics Financial Ratios

  • The Interest Expense is -0.14% of Operating Income.
  • Per Share Earnings over the last 9 years have been positive in 6 years.

Entero Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Current Symbol: ENTO
Website: enterothera.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ENTO Technical Analysis vs Fundamental Analysis

Sell
4
Entero Therapeutics (ENTO) is a Sell

Is Entero Therapeutics a Buy or a Sell?